ArticleThe New England journal of medicine2011
Promising advances in the treatment of malignant pancreatic endocrine tumors.
Article in The New England journal of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Real-world study of everolimus in advanced progressive neuroendocrine tumors.The oncologist · 2014Trial
- Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours.European journal of nuclear medicine and molecular imaging · 2014Trial
- Clinicopathological Features and Prognosis Analysis of Primary Bile Duct and Ampullary Neuroendocrine Neoplasms: A Population-Based Study from 1975 to 2016.Current oncology (Toronto, Ont.) · 2022Article
- Clinical remission of an inoperable malignant insulinoma by the combination treatment with octreotide and everolimus.Journal of general and family medicine · 2019Article
- Primary hepatic neuroendocrine carcinoma: report of two cases and literature review.BMC clinical pathology · 2018Article
- Article
- Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.Current oncology (Toronto, Ont.) · 2015Article
- Therapy for metastatic pancreatic neuroendocrine tumors.Annals of translational medicine · 2014Review
- Zollinger-Ellison syndrome: recent advances and controversies.Current opinion in gastroenterology · 2013Review
- Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI.La Radiologia medica · 2013Article
- Article
- Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.Biochimica et biophysica acta · 2013Article
- Pharmacotherapy of Zollinger-Ellison syndrome.Expert opinion on pharmacotherapy · 2013Review
- Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problems.International journal of molecular sciences · 2012Review
- Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011.Current oncology (Toronto, Ont.) · 2012Article
- Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.Journal of gastroenterology · 2012Review
- Lymph nodes and survival in pancreatic neuroendocrine tumors.Archives of surgery (Chicago, Ill. : 1960) · 2012Article
- [Medicinal therapy of metastasized neuroendocrine tumors of the gastroenteropancreatic system.]Der Internist · 2012Article
- ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.Neuroendocrinology · 2012Article
- Cancer: a roadmap for the land of small tumors.Nature reviews. Endocrinology · 2011Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
21306243What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.